- Governance Task Force Wants to Hear from You–Watch a webinar to learn more and provide your thoughts.
- Advocacy in Action: Medicare Drug Payments, Diabetes Drug Safety Rules, Gender, Birth Control, and more...
- Midlife Women Transitioning to Menopause Have a Higher Risk of Metabolic Syndrome, Which Predisposes to Heart Disease and Type 2 Diabetes
- New Rules: Medicare Now Extends Coverage of CGMs
- Biomarkers Can Predict Whether Women with Endometriosis Will Respond to the First-Line Treatment
- Deep in the Heart of Texas–Pediatric endocrinologist Stephanie Sisley, MD, at the Texas Children’s Hospital in Houston talks about her research looking at genetic causes of obesity in children and why diet and exercise are simply not enough for these patients.
ENDO 2019 is coming to the vibrant city of New Orleans, Louisiana, March 23–26, 2019.
ENDO represents a convergence of science and practice that not only highlights but also facilitates breakthrough discoveries in the field of endocrinology.
This is a can't-miss event, with world-renowned plenary speakers, enhanced Science Pathways, a brand-new Bioinformatics Workshop, and much more. ENDO 2019 is your opportunity to learn about the most cutting-edge science in the field while connecting with peers and colleagues.
Take advantage of Early Registration savings and register today!
The end of 2018 marks the first five-year deadline since the implementation of ABIM’s continuous MOC program. Claim your points now from any 2018 Endocrine Society educational activities you participated in. Still need points? View our CME activities.
This month, we will be hosting a Twitter Chat to discuss diabetes technology; where it's been, where it is, and where it's going. Join us, Society member Dr. Jennifer Sherr, and our Chief Professional and Clinical Affairs Officer Dr. Robert Lash for our chat on November 13 from 1-2 PM EST.
The Processes of Anterior Pituitary Hormone Pulse Generation
We describe some examples of the clinical implications of recognizing the importance of the pituitary and target organs in pulse generation and suggest avenues for future research in both the short and long term.
Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine
We describe patients with RAIR differentiated thyroid cancers receiving targeted therapy with demonstrated RAI uptake allowing for iodine-131 administration.
It is the purpose of the current review to update the evidence regarding the pathogenesis of PCOS and emphasize how new data are providing insights into diagnosis and treatment of the disorder.
A Pre-Pregnancy Biomarker Risk Score Improves Prediction of Future Gestational Diabetes
Previous studies have not examined the ability of multiple preconception biomarkers, considered together, to improve prediction of gestational diabetes mellitus.